miR-15b
|
CMs |
pro-apoptosis; via targeting Arl2 and Bcl2 |
LNA antimiR |
-
|
[72] |
miR-21-5p
|
M1 macrophages and endothelial cells |
anti-inflammation and pro-angiogenesis; via targeting SPRY1/VEGFA and PDGF-BB signaling |
agomiR + nanoparticles |
- |
[79] |
miR-92a
|
endothelial cells |
anti-angiogenesis; via targeting pro-angiogenic protein Itga5 |
antagomir |
Yes |
[54,75] |
miR-146b-5p
|
CFs, endothelial cells and macrophages |
pro-fibrotic, anti-angiogenesis and inhibit reparative macrophages; via targeting interleukin 1 receptor associated kinase 1 (IRAK1) and carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1) |
antagomir |
- |
[81] |
miR-199a-3p
|
CMs |
pro-proliferative; via targeting Hippo/YAP1 pathway via TAOK1, β-TrCP and Cofilin2 |
AAV6 |
- |
[63] |